Quantbot Technologies LP Clovis Oncology, Inc. Transaction History

Quantbot Technologies LP

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 11, 2022	SELL	$2.7 - $4.76 $4,293 - $7,568	-1,590 Closed	0 $0
Q3 2021 Nov 09, 2021	SELL	$4.06 - $5.8 $1,806 - $2,581	-445 Reduced 21.87%	1,590 $7,000
Q2 2021 Aug 12, 2021	BUY	$5.02 - $7.05 $10,215 - $14,346	2,035 New	2,035 $11,000
Q2 2020 Aug 13, 2020	SELL	$5.69 - $9.69 $130 - $222	-23 Closed	0 $0
Q1 2020 May 13, 2020	SELL	$3.77 - $11.0 $1,006 - $2,937	-267 Reduced 92.07%	23 $0
Q4 2019 Feb 10, 2020	SELL	$3.0 - $16.43 $7,230 - $39,596	-2,410 Reduced 89.26%	290 $3,000
Q3 2019 Nov 12, 2019	BUY	$3.93 - $15.35 $3,537 - $13,815	900 Added 50.0%	2,700 $10,000
Q2 2019 Aug 13, 2019	BUY	$12.81 - $25.67 $23,058 - $46,206	1,800 New	1,800 $26,000
Q2 2018 Aug 13, 2018	SELL	$42.06 - $62.4 $116,968 - $173,534	-2,781 Closed	0 $0
Q1 2018 May 11, 2018	BUY	$50.12 - $67.72 $139,383 - $188,329	2,781 New	2,781 $146,000

166

Ticker CLVS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 144,480,000
Market Cap $13M
Description
Clovis Oncology, Inc., a biopharmaceutical company, focuses on acquiring, developing, and commercializing anti-cancer agents in the United States, Europe, and internationally. In the U.S., the company offers Rubraca (rucaparib), an oral small molecule inhibitor of poly ADP-ribose polymerase for recurrent epithelial ovarian, fallopian tube, or pr...

Get notified when there are updates to the investment portfolio of Quantbot Technologies LP, based on Form 13F filings with the SEC.

Stay updated on Quantbot Technologies LP with notifications on news.